# Epigenetic therapy inhibits metastases by disrupting premetastatic niches

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/epigenetic-therapy-inhibits-metastases-by-disrupting-premetastatic-niches/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Zhihao Lü,Jianling Zou,Shuang Li,Michael J. Topper,Yong Tao,Hao Zhang,Xi Jiao,Wenbing Xie,Xiangqian Kong,Michelle Vaz,Huili Li,Yi Cai,Limin Xia,Peng Huang,Kristen Rodgers,Beverly Lee,Joanne Riemer,Chi-Ping Day,Ray-Whay Chiu Yen,Ying Cui,Yujiao Wang,Yanni Wang,Weiqiang Zhang,Hariharan Easwaran,Alicia Hulbert,KiBem Kim,Rosalyn A. Juergens,Stephen C. Yang,Richard J. Battafarano,Errol L. Bush,Stephen Broderick,Stephen M. Cattaneo,Julie R. Brahmer,Charles M. Rudin,John Wrangle,Yuping Mei,Young J. Kim,Bin Zhang,Ken Kang‐Hsin Wang,Patrick M. Forde,Joseph B. Margolick,Barry D. Nelkin,Cynthia A. Zahnow,Drew M. Pardoll,Franck Housseau,Stephen B. Baylin,Lin Shen,Malcolm V. Brock |
| Citations | 339 |
| DOI | 10.1038/s41586-020-2054-x |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/8765085 |
| OpenAlex ID | https://openalex.org/W3006996572 |
| PMID | 32103175 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Julie R. Brahmer](https://scholariq.org/researchers/julie-r-brahmer/)
- [Charles M. Rudin](https://scholariq.org/researchers/charles-m-rudin/)
- [Patrick M. Forde](https://scholariq.org/researchers/patrick-m-forde/)
- [Errol L. Bush](https://scholariq.org/researchers/errol-l-bush/)

## Paper journal

- [Nature](https://scholariq.org/journals/nature/)

## Paper primary topic

- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)

## Paper topics

- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.